2D/3D-QSAR Model Development Based on a Quinoline Pharmacophoric Core for the Inhibition of Plasmodium falciparum : An In Silico Approach with Experimental Validation
Malaria is an infectious disease caused by spp. parasites, with widespread drug resistance to most antimalarial drugs. We report the development of two 3D-QSAR models based on comparative molecular field analysis (CoMFA), comparative molecular similarity index analysis (CoMSIA), and a 2D-QSAR model,...
Saved in:
Published in | Pharmaceuticals (Basel, Switzerland) Vol. 17; no. 7; p. 889 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
04.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Malaria is an infectious disease caused by
spp. parasites, with widespread drug resistance to most antimalarial drugs. We report the development of two 3D-QSAR models based on comparative molecular field analysis (CoMFA), comparative molecular similarity index analysis (CoMSIA), and a 2D-QSAR model, using a database of 349 compounds with activity against the
3D7 strain. The models were validated internally and externally, complying with all metrics (q
> 0.5, r
> 0.6, r
> 0.5, etc.). The final models have shown the following statistical values: r
CoMFA = 0.878, r
CoMSIA = 0.876, and r
2D-QSAR = 0.845. The models were experimentally tested through the synthesis and biological evaluation of ten quinoline derivatives against
3D7. The CoMSIA and 2D-QSAR models outperformed CoMFA in terms of better predictive capacity (MAE = 0.7006, 0.4849, and 1.2803, respectively). The physicochemical and pharmacokinetic properties of three selected quinoline derivatives were similar to chloroquine. Finally, the compounds showed low cytotoxicity (IC
> 100 µM) on human HepG2 cells. These results suggest that the QSAR models accurately predict the toxicological profile, correlating well with experimental in vivo data. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1424-8247 1424-8247 |
DOI: | 10.3390/ph17070889 |